Description
The VA VISN 22 Network Contracting Office is conducting a Sources‑Sought RFI to identify qualified vendors capable of supplying FDA‑approved reagents, consumables, and related kits for the Optilite clinical chemistry analyzer. The solicitation seeks a base‑year supply with four optional one‑year extensions, covering specific reagents (Freelite Kappa, Freelite Lambda, Ceruloplasmin) and consumables (cuvettes, sample cups, washing solutions, diluents). Vendors must be authorized distributors or manufacturers, cannot offer remanufactured or gray‑market items, and must meet strict performance and stability specifications. Responses should include company size classification, SDVOSB/VOSB status, manufacturing or distribution capabilities, and any “equal‑to” item information. Pricing is optional but encouraged for planning purposes.
• Required items: 9 specific reagents/consumables for Optilite analyzer.
• Must be FDA‑approved and OEM‑authorized; no substitution or reuse allowed.
• Base year + up to four 1‑year option years (potential 5‑year contract).
• NAICS 325413 (In‑Vitro Diagnostic Substance Manufacturing).
• Target audience: manufacturers or authorized distributors; small‑business status queried.
• Response deadline: 9 AM PST, September 7 2026 (email only).
• No contract award date or award value disclosed; this is a planning‑only RFI.